Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Hiroshi Azuma
Hiroshi Azuma, Tsukuba-Shi JP
| Patent application number | Description | Published |
|---|---|---|
| 20100190783 | TRIAZOLONE DERIVATIVES - A Compound represented by the following general formula (1): | 07-29-2010 |
| 20100240654 | HYDRAZIDE DERIVATIVES - A compound represented by the following general formula (1) or a salt thereof or a hydrate of the foregoing is safe while exhibiting suitable physicochemical stability, and is useful as therapeutic or prophylactic agents for diseases associated with thrombus formation. | 09-23-2010 |
| 20110112109 | TRIAZOLONE DERIVATIVES - A compound represented by the following general formula (1) or salts thereof or hydrates of the foregoing: | 05-12-2011 |
Hiroshi Azuma, Kyoto-Shi JP
| Patent application number | Description | Published |
|---|---|---|
| 20100188372 | Information input device, and electronic apparatus using same - An information input device is provided which is to make input of information by operating a disk-shaped rotating member. The device includes the rotating member ( | 07-29-2010 |
| 20100188373 | Information input device, and electronic apparatus using same - An information input device is provided which is to make input of information by operating a disk-shaped rotating member. The device includes the rotating member ( | 07-29-2010 |
Hiroshi Azuma, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20090149481 | PHARMACEUTICAL COMPOSITION AND BEVERAGE COMPOSITION COMPRISING L-ARGININE - A pharmaceutical composition and a beverage composition comprising the following three components (A), (B) and (C): (A) L-arginine or a salt thereof; (B) caffeine or a salt thereof; and (C) at least one substance selected from the group consisting of vitamin C or a derivative thereof, vitamin E or a derivative thereof and folic acid or a derivative thereof. The compositions show an effect of L-arginine even at a low L-arginine content, and therefore can be suitably used for the prevention, amelioration and/or treatment of at least one disease selected from the group consisting of arteriosclerosis, angiectasia, hyperlipemia, climacteric disorder, diabetes, angina pectoris, hypertension, erectile dysfunction, thrombosis, immunodeficiency, dementia, gestosis, respiratory failure and hemorrhoid, in the form of a pharmaceutical preparation or a beverage. | 06-11-2009 |
| 20100040666 | Method for Control of Drug Elution Rate and Composition for Coating of Drug-Eluting Stent - Disclosed are a method for controlling the elution of a drug from a stent and a drug-eluting stent capable of reducing the restenosis rate after therapy. A coating composition for a drug-eluting stent comprising an endothelin receptor antagonist and a copolymer of 2-methacryloyloxyethyl phosphorylcholine and n-butyl methacrylate. The elution of the endothelin receptor antagonist from the coating composition can be controlled by varying the ratio of 2-methacryloyloxyethyl phosphorylcholine to n-butyl methacrylate in the copolymer. | 02-18-2010 |
| 20100160353 | PHARMACEUTICAL COMPOSITION AND BEVERAGE COMPOSITION COMPRISING L-ARGININE - A pharmaceutical composition and a beverage composition comprising the following three components (A), (B) and (C): (A) L-arginine or a salt thereof; (B) caffeine or a salt thereof; and (C) at least one substance selected from the group consisting of vitamin C or a derivative thereof, vitamin E or a derivative thereof and folic acid or a derivative thereof. The compositions show an effect of L-arginine even at a low L-arginine content, and therefore can be suitably used for the prevention, amelioration and/or treatment of at least one disease selected from the group consisting of arteriosclerosis, angiectasia, hyperlipemia, climacteric disorder, diabetes, angina pectoris, hypertension, erectile dysfunction, thrombosis, immunodeficiency, dementia, gestosis, respiratory failure and hemorrhoid, in the form of a pharmaceutical preparation or a beverage. | 06-24-2010 |
Hiroshi Azuma, Nomi-Shi JP
| Patent application number | Description | Published |
|---|---|---|
| 20080278644 | LIQUID CRYSTAL DISPLAY DEVICE - A liquid crystal display device includes a liquid crystal display panel having a display section which is composed of a plurality of display pixels, a driving unit which drives the display pixels, and a control unit which controls the driving unit. A first substrate includes pixel electrodes which are disposed in association with the plurality of display pixels. A second substrate includes a counter-electrode which is opposed to the plurality of pixel electrodes. A pair of alignment films are disposed on the plurality of pixel electrodes and the counter-electrode, and control an alignment state of liquid crystal molecules, which are included in the liquid crystal layer, by rubbing treatment. Dummy display pixels are disposed on a terminal end side of the display section in a rubbing direction. A driving unit includes circuit for cyclically applying a reverse transition prevention signal to the dummy display pixels. | 11-13-2008 |
Hiroshi Azuma, Osaka JP
| Patent application number | Description | Published |
|---|---|---|
| 20120062522 | INFORMATION INPUT DEVICE, AND ELECTRONIC APPARATUS USING SAME - An information input device is provided which is to make input of information by operating a disk-shaped rotating member. The device includes the rotating member ( | 03-15-2012 |